Faculty Members

Dr.Alhussain Hamood Yahya Aodah

Associate Professor College of Pharmacy AL-Kharj

Kharj
011-588-0115886043
a.aodah@psau.edu.sa

Curriculum Vitae
Publications

Education

Bachelor in Pharmaceutical Science from the College of Pharmacy, King Saud University, in Riyadh, Saudi Arabia.
Ph.D. of pharmaceutics and Drug Delivery track, College of Pharmacy, Nova Southeastern University, Florida

Research Interests

Drug delivery System, Formulations, Nanochrystals.

Experience

2009 - 2017 - Teacher Assistant - Sattam bin Abdulaziz University
2017 - until now - Assistant Professor - Sattam bin Abdulaziz University
2008 - 2009 - Pharmacist - Security Forces Hospital

Publications

1. Sahoo, A., Altemani, F. H., Alsaidan, O. A., Alsenani, F., Aodah, A., Alrobaian, M., Almalki, W. H., Almujri, S. S., Lal, J. A., & Singh, J. (2026). Nano-Based Therapeutics in Rare Disease Management: Current Perspectives, Challenges, and Unmet Needs. *Current Neuropharmacology*.
2. Singh, J., Alsaidan, O. A., Aodah, A., Alrobaian, M., Almalki, W. H., Almujri, S. S., Sahoo, A., Alam, K., Lal, J. A., & Barkat, M. A. (2026). Artificial intelligence in breast cancer: clinical applications in diagnosis, prognosis, and therapeutics. *Future Oncology*, *22*(2), 249-269.
3. Yadav, P. K., Alsaidan, O. A., Altemani, F. H., Alsenani, F., Aodah, A., Almalki, W. H., Almujri, S. S., Alrobaian, M., Sahoo, A., & Rahman, M. (2026). Advancing Regenerative Medicine with 3D Bioprinting: Techniques, Biomaterials, and Clinical Applications. *Current Medicinal Chemistry*.
4. Alqarni, M. H., Imran, M., Foudah, A. I., Hasmi, S., Aodah, A. H., & Alam, A. (2025). Dissolving Microneedle Transdermal Patch Loaded with Nanoliposomes of Enicostemma littorale for the Management of Type II Diabetes. *ACS omega*, *10*(25), 26468-26477.
5. Alruwaili, N. K., Almalki, W. H., Almujri, S. S., Alhamyani, A., Alzahrani, A., Aodah, A., Alrobaian, M., Singh, T., Barkat, M. A., & Alanezi, A. A. (2025). Phospholipid-based nanolipid carriers for dual kinase inhibitors in triple-negative breast cancer. *Nanomedicine*, *20*(15), 1865-1880.
6. Alsulays, B. B., Anwer, M. K., Imam, F., & Aodah, A. H. (2025). Co-delivery of vinorelbine and rutin by lipid polymer nanoparticles for enhanced liver cancer chemotherapy. *Journal of Drug Delivery Science and Technology*, *104*, 106490.
7. Balaha, M., Negm, W. A., Elekhnawy, E., Aldossari, R. M., Aodah, A. H., Alam, A., Ahmed, N., & Balaha, M. F. (2025). Toward plant-based therapeutics: Unravelling the antibacterial, antibiofilm, and antiquorum-sensing actions of Acacia saligna extract. *Microbial Pathogenesis*, 108238.
8. Dwivedi, K., Sahoo, A., Almalki, W. H., Almujri, S. S., Aodah, A., Alruwaili, N. K., Rab, S. O., Alanezi, A. A., Haji, E. M., & Barkat, M. A. (2025). Innovative nanocarrier systems for enhanced delivery of phyto-active compounds in cancer therapy. *Nanomedicine*, *20*(1), 91-116.
9. Kumar, S., Khan, A. A., Ansari, M. J., Aodah, A., & Al-Shdefat, R. I. K. (2025). Chrono-drug Delivery Systems: Timed-release Formulations. *Chronopharmacology*, 140-163.
10. Mandal, A. K., Sahoo, A., Almalki, W. H., Almujri, S. S., Alhamyani, A., Aodah, A., Alruwaili, N. K., Abdul Kadir, S. Z. B. S., Mandal, R. K., & Almalki, R. A. (2025). Phytoactives for Obesity Management: Integrating Nanomedicine for Its Effective Delivery. *Nutrition Reviews*, *83*(6), 1152-1170.
11. Rahman, M., Singh, J., Aodah, A., Alrobaian, M., Alruwaili, N. K., Almalki, W. H., Almujri, S. S., Rab, S. O., Madkhali, O. A., & Sahoo, A. (2025). Chiral nanosystem and chiral supraparticles for drug delivery: an expert opinion. *Expert Opinion on Drug Delivery*, *22*(2), 143-162.
12. Sahoo, A., Singh, J., Alam, K., Alruwaili, N. K., Aodah, A., Almalki, W. H., Almujri, S. S., Alrobaian, M., Barkat, M. A., & Singh, T. (2025). Medical Artificial Intelligence: Opportunities and Challenges In Infectious Disease Management. *Current Medicinal Chemistry*.
13. Sahoo, A., Singh, J., Alam, K., Alruwaili, N. K., Aodah, A., Almalki, W. H., Almujri, S. S., Alrobaian, M., Barkat, M. A., & Singh, T. (2025). Addressing Unmet Needs in Clostridium difficile Infection: Advances in Diagnosis, Treatment, and Prevention. *Current Medicinal Chemistry*.
14. Singh, J., Alruwaili, N. K., Aodah, A., Almalki, W. H., Almujri, S. S., Alrobaian, M., Rab, S. O., Alanezi, A. A., Haji, E. M., & Barkat, M. A. (2025). Gold nanoclusters in cancer drug delivery: advances and emerging applications. *Journal of Drug Delivery Science and Technology*, *105*, 106594.
15. Alruwaili, N. K., Almalki, W. H., Almujri, S. S., Alhamyani, A., Alzahrani, A., Aodah, A., Alrobaian, M., Singh, T., Ahmad, F. J., & Singh, A. (2024). Hispolon-loaded lipid nanocapsules for the management of hepatocellular carcinoma: comparative study with solid lipid nanoparticles and suspension. *Nanomedicine*, *19*(30), 2555-2576.
16. Alsulays, B. B., Aodah, A. H., Ahmed, M. M., & Anwer, M. K. (2024). Preparation and evaluation of chitosan coated PLGA nanoparticles encapsulating ivosidenib with enhanced cytotoxicity against human liver cancer cells. *International Journal of Nanomedicine*, 3461-3473.
17. Aodah, A. H., Alkholifi, F. K., Alharthy, K. M., Devi, S., Foudah, A. I., Yusufoglu, H. S., & Alam, A. (2024). Effects of kaempherol-3-rhamnoside on metabolic enzymes and AMPK in the liver tissue of STZ-induced diabetes in mice. *Scientific Reports*, *14*(1), 16167.
18. Rahman, M., Sahoo, A., Almalki, W. H., Almujri, S. S., Aodah, A., Alnofei, A. A., & Alhamyani, A. (2024). Three-dimensional cell culture: Future scope in cancer vaccine development. *Drug Discovery Today*, *29*(9), 104114.
19. Ahmed, M. M., Fatima, F., Alnami, A., Alsenaidy, M., Aodah, A. H., Aldawsari, M. F., Almutairy, B., Anwer, M. K., & Jafar, M. (2023). Design and characterization of baricitinib incorporated PLA 3D printed pills by fused deposition modeling: An oral pill for treating alopecia areata. *Polymers*, *15*(8), 1825.
20. Alkholifi, F. K., Aodah, A. H., Foudah, A. I., & Alam, A. (2023). Exploring the therapeutic potential of berberine and tocopherol in managing diabetic neuropathy: a comprehensive approach towards alleviating chronic neuropathic pain. *Biomedicines*, *11*(6), 1726.
21. Alkholifi, F., Aodah, A., Foudah, A., & Alam, A. (2023). Exploring the therapeutic potential of berberine and tocopherol in managing diabetic neuropathy: A comprehensive approach towards alleviating chronic neuropathic pain. *Biomedicines*, *11*(6), 1726.
22. Alnasser, S. M., Azam, F., Alqarni, M. H., Aodah, A. H., Hashmi, S., Kamal, M., Meshal, A., & Alam, A. (2023). Development and evaluation of novel encapsulated isoeugenol-liposomal gel carrier system for methicillin-resistant Staphylococcus aureus. *Gels*, *9*(3), 228.
23. Alqarni, M. H., Foudah, A. I., Aodah, A. H., Alkholifi, F. K., Salkini, M. A., & Alam, A. (2023). Caraway nanoemulsion gel: a potential antibacterial treatment against Escherichia coli and Staphylococcus aureus. *Gels*, *9*(3), 193.
24. Alsulays, B. B., Anwer, M. K., Aodah, A. H., & Imam, F. (2023). Novel lansoprazole/glycyrrhizin spray dried complex: Physiochemical properties, photostability, and anti-ulcer activity on rats. *Journal of Drug Delivery Science and Technology*, *90*, 105146.
25. Aodah, A. H., Balaha, M. F., Jawaid, T., Khan, M. M., Ansari, M. J., & Alam, A. (2023). Aegle marvels (L.) Correa leaf essential oil and its phytoconstituents as an anticancer and anti-Streptococcus mutans agent. *Antibiotics*, *12*(5), 835.
26. Aodah, A. H., Devi, S., Alkholifi, F. K., Yusufoglu, H. S., Foudah, A. I., & Alam, A. (2023). Effects of taraxerol on oxidative and inflammatory mediators in isoproterenol-induced cardiotoxicity in an animal model. *Molecules*, *28*(10), 4089.
27. Aodah, A. H., Hashmi, S., Akhtar, N., Ullah, Z., Zafar, A., Zaki, R. M., Khan, S., Ansari, M. J., Jawaid, T., & Alam, A. (2023). Formulation development, optimization by box–behnken design, and in vitro and ex vivo characterization of hexatriacontane-loaded transethosomal gel for antimicrobial treatment for skin infections. *Gels*, *9*(4), 322.
28. Balaha, M. F., Alamer, A. A., Aldossari, R. M., Aodah, A. H., Helal, A. I., & Kabel, A. M. (2023). Amentoflavone mitigates cyclophosphamide-induced pulmonary toxicity: involvement of-SIRT-1/Nrf2/Keap1 Axis, JAK-2/STAT-3 signaling, and apoptosis. *Medicina*, *59*(12), 2119.
29. Gupta, M. S., Kumar, T. P., Reddy, D., Pathak, K., Gowda, D. V., Babu, A. N., Aodah, A. H., Khafagy, E.-S., Alotaibi, H. F., & Abu Lila, A. S. (2023). Development and characterization of pullulan-based orodispersible films of iron. *Pharmaceutics*, *15*(3), 1027.
30. Rathee, A., Solanki, P., Verma, S., Vohora, D., Ansari, M. J., Aodah, A., Kohli, K., & Sultana, Y. (2023). Simultaneous determination of posaconazole and hemp seed oil in nanomicelles through RP-HPLC via a quality-by-design approach. *ACS omega*, *8*(33), 30057-30067.
31. Shamim, A., Ansari, M. J., Aodah, A., Iqbal, M., Aqil, M., Mirza, M. A., Iqbal, Z., & Ali, A. (2023). QbD-engineered development and validation of a RP-HPLC method for simultaneous estimation of rutin and ciprofloxacin HCl in bilosomal nanoformulation. *ACS omega*, *8*(24), 21618-21627.
32. Fayed, M. H., Aldawsari, M. F., AlAli, A. S., Alsaqr, A., Almutairy, B. K., Aodah, A. H., Tawfeek, H. M., Khafagy, E.-S., & Helal, D. A. (2022). Design-of-experiment approach to quantify the effect of nano-sized silica on tableting properties of microcrystalline cellulose to facilitate direct compression tableting of binary blend containing a low-dose drug. *Journal of Drug Delivery Science and Technology*, *68*, 103127.
33. Zacharakis, G., Albadrani, A. A., Aodah, A., Agarwal, K., & Ayub, R. (2022). An Investigation into the State of the Art and Perspective for Medical Field in Reference with Artificial Intelligence. *Journal of Pharmaceutical Negative Results*, *13*(4), 1564-1571.
34. Aodah, A. H., Fayed, M. H., Alalaiwe, A., Alsulays, B. B., Aldawsari, M. F., & Khafagy, E.-S. (2020). Design, optimization, and correlation of in vitro/in vivo disintegration of novel fast orally disintegrating tablet of high dose metformin hydrochloride using moisture activated dry granulation process and quality by design approach. *Pharmaceutics*, *12*(7), 598.
35. Alsulays, B. B., Anwer, M. K., Aldawsari, M. F., Aodah, A., Adam, E., Alshehri, S., & Abdel-Kader, M. S. (2019). Preparation and evaluation of a stable and sustained release of lansoprazole-loaded poly (d, l-lactide-co-glycolide) polymeric nanoparticles. *Journal of Polymer Engineering*, *39*(9), 822-829.
36. Aodah, A., Rawas-Qalaji, M., Bafail, R., & Rawas-Qalaji, M. (2019). Effect of fast-disintegrating tablets’ characteristics on the sublingual permeability of atropine sulfate for the potential treatment of organophosphates toxicity. *AAPS PharmSciTech*, *20*(6), 229.
37. Bafail, R., Rawas-Qalaji, M., Rawas-Qalaji, M., & Aodah, A. (2019). Effect of the filler grade on the characteristics and the sublingual permeability of atropine sulfate fast disintegrating sublingual tablets. *Drug Development and Industrial Pharmacy*, *45*(10), 1617-1623.
38. Aodah, A. (2017). *Formulation and Evaluation of Fast Disintegrating Sublingual Atropine Tablets for the Potential Treatment of Acute Organophosphates Toxicity* [Doctoral dissertation/Master's thesis, Nova Southeastern University].
39. Aodah, A., Bafail, R. S., & Rawas-Qalaji, M. (2017). Formulation and evaluation of fast-disintegrating sublingual tablets of atropine sulfate: the effect of tablet dimensions and drug load on tablet characteristics. *AAPS PharmSciTech*, *18*(5), 1624-1633.
40. Bafail, R., Alhussain, A., & Qalaji, M. (2016). Validation of a simple disintegration test for rapidly disintegrating tablets.
41. Bafail, R., Aodah, A., & Qalaji, M. (2016). Sublingual permeability of atropine sulfate using novel rapidly disintegrating tablets for the potential treatment of acute organophosphates.
42. Bafail, R., Aodah, A., & Qalaji, M. (2016). The effect of MCC grade on the physical properties of atropine sulfate rapidly disintegrating sublingual tablets.
43. Aodah, A., Bafail, R., & Rawas-Qalaji, M. (2015). Development and validation of a simple disintegration test for rapidly disintegrating tablets. *Orlando: American Association of Pharmaceutical Scientists Annual Meeting and Exposition*, R61.
44. AlHazme, R. H., Rana, A. M., & Aodah, A. (2014). Serious Arabic meaning, grammatical, and study design flaws in the study" Faxed Arabic Prescriptions: a medication error waiting to happen?". *International Journal of Medical Informatics*, *83*(8), 601-603.
45. Alaydi, L., Aodah, A., & Qalaji, M. R. (2014). Development and validation of HPLC method with PDA detector for simultaneous quantification of co-eluted compounds in pharmaceutical samples.
46. Aodah, A., Alaydi, L., & Qalaji, M. R. (2014). Validation of HPLC method and ultra violet detection for the quantification of atropine sulfate in aqueous samples.
47. Aodah, A., Mendez, B., Losada, A., & Qalaji, M. R. (2014). Fabrication and characterization of epinephrine nanocrystals using top-down technique.
48. Rawas-Qalaji, M., Kariman, A., Condon, M., Losada, A., Mandez, B., & Aodah, A. (2014). Formulation And Diffusion Of Epinephrine's Prodrug For Anaphylaxis Treatment.
```
1. Sahoo, A., Altemani, F. H., Alsaidan, O. A., Alsenani, F., Aodah, A., Alrobaian, M., Almalki, W. H., Almujri, S. S., Lal, J. A., & Singh, J. (2026). Nano-Based Therapeutics in Rare Disease Management: Current Perspectives, Challenges, and Unmet Needs. *Current Neuropharmacology*.
2. Singh, J., Alsaidan, O. A., Aodah, A., Alrobaian, M., Almalki, W. H., Almujri, S. S., Sahoo, A., Alam, K., Lal, J. A., & Barkat, M. A. (2026). Artificial intelligence in breast cancer: clinical applications in diagnosis, prognosis, and therapeutics. *Future Oncology*, *22*(2), 249–269.
3. Yadav, P. K., Alsaidan, O. A., Altemani, F. H., Alsenani, F., Aodah, A., Almalki, W. H., Almujri, S. S., Alrobaian, M., Sahoo, A., & Rahman, M. (2026). Advancing Regenerative Medicine with 3D Bioprinting: Techniques, Biomaterials, and Clinical Applications. *Current Medicinal Chemistry*.
4. Alqarni, M. H., Imran, M., Foudah, A. I., Hasmi, S., Aodah, A. H., & Alam, A. (2025). Dissolving Microneedle Transdermal Patch Loaded with Nanoliposomes of Enicostemma littorale for the Management of Type II Diabetes. *ACS Omega*, *10*(25), 26468–26477.
5. Alruwaili, N. K., Almalki, W. H., Almujri, S. S., Alhamyani, A., Alzahrani, A., Aodah, A., Alrobaian, M., Singh, T., Barkat, M. A., & Alanezi, A. A. (2025). Phospholipid-based nanolipid carriers for dual kinase inhibitors in triple-negative breast cancer. *Nanomedicine*, *20*(15), 1865–1880.
6. Alsulays, B. B., Anwer, M. K., Imam, F., & Aodah, A. H. (2025). Co-delivery of vinorelbine and rutin by lipid polymer nanoparticles for enhanced liver cancer chemotherapy. *Journal of Drug Delivery Science and Technology*, *104*, 106490.
7. Balaha, M., Negm, W. A., Elekhnawy, E., Aldossari, R. M., Aodah, A. H., Alam, A., Ahmed, N., & Balaha, M. F. (2025). Toward plant-based therapeutics: Unravelling the antibacterial, antibiofilm, and antiquorum-sensing actions of Acacia saligna extract. *Microbial Pathogenesis*, 108238.
8. Dwivedi, K., Sahoo, A., Almalki, W. H., Almujri, S. S., Aodah, A., Alruwaili, N. K., Rab, S. O., Alanezi, A. A., Haji, E. M., & Barkat, M. A. (2025). Innovative nanocarrier systems for enhanced delivery of phyto-active compounds in cancer therapy. *Nanomedicine*, *20*(1), 91–116.
9. Kumar, S., Khan, A. A., Ansari, M. J., Aodah, A., & Al-Shdefat, R. I. K. (2025). Chrono-drug Delivery Systems: Timed-release Formulations. *Chronopharmacology*, 140–163.
10. Mandal, A. K., Sahoo, A., Almalki, W. H., Almujri, S. S., Alhamyani, A., Aodah, A., Alruwaili, N. K., Abdul Kadir, S. Z. B. S., Mandal, R. K., & Almalki, R. A. (2025). Phytoactives for Obesity Management: Integrating Nanomedicine for Its Effective Delivery. *Nutrition Reviews*, *83*(6), 1152–1170.
11. Rahman, M., Singh, J., Aodah, A., Alrobaian, M., Alruwaili, N. K., Almalki, W. H., Almujri, S. S., Rab, S. O., Madkhali, O. A., & Sahoo, A. (2025). Chiral nanosystem and chiral supraparticles for drug delivery: an expert opinion. *Expert Opinion on Drug Delivery*, *22*(2), 143–162.
12. Sahoo, A., Singh, J., Alam, K., Alruwaili, N. K., Aodah, A., Almalki, W. H., Almujri, S. S., Alrobaian, M., Barkat, M. A., & Singh, T. (2025). Addressing Unmet Needs in Clostridium difficile Infection: Advances in Diagnosis, Treatment, and Prevention. *Current Medicinal Chemistry*.
13. Sahoo, A., Singh, J., Alam, K., Alruwaili, N. K., Aodah, A., Almalki, W. H., Almujri, S. S., Alrobaian, M., Barkat, M. A., & Singh, T. (2025). Medical Artificial Intelligence: Opportunities and Challenges In Infectious Disease Management. *Current Medicinal Chemistry*.
14. Singh, J., Alruwaili, N. K., Aodah, A., Almalki, W. H., Almujri, S. S., Alrobaian, M., Rab, S. O., Alanezi, A. A., Haji, E. M., & Barkat, M. A. (2025). Gold nanoclusters in cancer drug delivery: advances and emerging applications. *Journal of Drug Delivery Science and Technology*, *105*, 106594.
15. Alruwaili, N. K., Almalki, W. H., Almujri, S. S., Alhamyani, A., Alzahrani, A., Aodah, A., Alrobaian, M., Singh, T., Ahmad, F. J., & Singh, A. (2024). Hispolon-loaded lipid nanocapsules for the management of hepatocellular carcinoma: comparative study with solid lipid nanoparticles and suspension. *Nanomedicine*, *19*(30), 2555–2576.
16. Alsulays, B. B., Aodah, A. H., Ahmed, M. M., & Anwer, M. K. (2024). Preparation and evaluation of chitosan coated PLGA nanoparticles encapsulating ivosidenib with enhanced cytotoxicity against human liver cancer cells. *International Journal of Nanomedicine*, 3461–3473.
17. Aodah, A. H., Alkholifi, F. K., Alharthy, K. M., Devi, S., Foudah, A. I., Yusufoglu, H. S., & Alam, A. (2024). Effects of kaempherol-3-rhamnoside on metabolic enzymes and AMPK in the liver tissue of STZ-induced diabetes in mice. *Scientific Reports*, *14*(1), 16167.
18. Rahman, M., Sahoo, A., Almalki, W. H., Almujri, S. S., Aodah, A., Alnofei, A. A., & Alhamyani, A. (2024). Three-dimensional cell culture: Future scope in cancer vaccine development. *Drug Discovery Today*, *29*(9), 104114.
19. Ahmed, M. M., Fatima, F., Alnami, A., Alsenaidy, M., Aodah, A. H., Aldawsari, M. F., Almutairy, B., Anwer, M. K., & Jafar, M. (2023). Design and characterization of baricitinib incorporated PLA 3D printed pills by fused deposition modeling: An oral pill for treating alopecia areata. *Polymers*, *15*(8), 1825.
20. Alkholifi, F. K., Aodah, A. H., Foudah, A. I., & Alam, A. (2023). Exploring the therapeutic potential of berberine and tocopherol in managing diabetic neuropathy: A comprehensive approach towards alleviating chronic neuropathic pain. *Biomedicines*, *11*(6), 1726.
21. Alnasser, S. M., Azam, F., Alqarni, M. H., Aodah, A. H., Hashmi, S., Kamal, M., Meshal, A., & Alam, A. (2023). Development and evaluation of novel encapsulated isoeugenol-liposomal gel carrier system for methicillin-resistant Staphylococcus aureus. *Gels*, *9*(3), 228.
22. Alqarni, M. H., Foudah, A. I., Aodah, A. H., Alkholifi, F. K., Salkini, M. A., & Alam, A. (2023). Caraway nanoemulsion gel: a potential antibacterial treatment against Escherichia coli and Staphylococcus aureus. *Gels*, *9*(3), 193.
23. Alsulays, B. B., Anwer, M. K., Aodah, A. H., & Imam, F. (2023). Novel lansoprazole/glycyrrhizin spray dried complex: Physiochemical properties, photostability, and anti-ulcer activity on rats. *Journal of Drug Delivery Science and Technology*, *90*, 105146.
24. Aodah, A. H., Balaha, M. F., Jawaid, T., Khan, M. M., Ansari, M. J., & Alam, A. (2023). Aegle marvels (L.) Correa leaf essential oil and its phytoconstituents as an anticancer and anti-Streptococcus mutans agent. *Antibiotics*, *12*(5), 835.
25. Aodah, A. H., Devi, S., Alkholifi, F. K., Yusufoglu, H. S., Foudah, A. I., & Alam, A. (2023). Effects of taraxerol on oxidative and inflammatory mediators in isoproterenol-induced cardiotoxicity in an animal model. *Molecules*, *28*(10), 4089.
26. Aodah, A. H., Hashmi, S., Akhtar, N., Ullah, Z., Zafar, A., Zaki, R. M., Khan, S., Ansari, M. J., Jawaid, T., & Alam, A. (2023). Formulation development, optimization by box–behnken design, and in vitro and ex vivo characterization of hexatriacontane-loaded transethosomal gel for antimicrobial treatment for skin infections. *Gels*, *9*(4), 322.
27. Balaha, M. F., Alamer, A. A., Aldossari, R. M., Aodah, A. H., Helal, A. I., & Kabel, A. M. (2023). Amentoflavone mitigates cyclophosphamide-induced pulmonary toxicity: involvement of-SIRT-1/Nrf2/Keap1 Axis, JAK-2/STAT-3 signaling, and apoptosis. *Medicina*, *59*(12), 2119.
28. Gupta, M. S., Kumar, T. P., Reddy, D., Pathak, K., Gowda, D. V., Babu, A. N., Aodah, A. H., Khafagy, E.-S., Alotaibi, H. F., & Abu Lila, A. S. (2023). Development and characterization of pullulan-based orodispersible films of iron. *Pharmaceutics*, *15*(3), 1027.
29. Rathee, A., Solanki, P., Verma, S., Vohora, D., Ansari, M. J., Aodah, A., Kohli, K., & Sultana, Y. (2023). Simultaneous determination of posaconazole and hemp seed oil in nanomicelles through RP-HPLC via a quality-by-design approach. *ACS Omega*, *8*(33), 30057–30067.
30. Shamim, A., Ansari, M. J., Aodah, A., Iqbal, M., Aqil, M., Mirza, M. A., Iqbal, Z., & Ali, A. (2023). QbD-engineered development and validation of a RP-HPLC method for simultaneous estimation of rutin and ciprofloxacin HCl in bilosomal nanoformulation. *ACS Omega*, *8*(24), 21618–21627.
31. Fayed, M. H., Aldawsari, M. F., AlAli, A. S., Alsaqr, A., Almutairy, B. K., Aodah, A. H., Tawfeek, H. M., Khafagy, E.-S., & Helal, D. A. (2022). Design-of-experiment approach to quantify the effect of nano-sized silica on tableting properties of microcrystalline cellulose to facilitate direct compression tableting of binary blend containing a low-dose drug. *Journal of Drug Delivery Science and Technology*, *68*, 103127.
32. Zacharakis, G., Albadrani, A. A., Aodah, A., Agarwal, K., & Ayub, R. (2022). An Investigation into the State of the Art and Perspective for Medical Field in Reference with Artificial Intelligence. *Journal of Pharmaceutical Negative Results*, *13*(4), 1564–1571.
33. Aodah, A. H., Fayed, M. H., Alalaiwe, A., Alsulays, B. B., Aldawsari, M. F., & Khafagy, E.-S. (2020). Design, optimization, and correlation of in vitro/in vivo disintegration of novel fast orally disintegrating tablet of high dose metformin hydrochloride using moisture activated dry granulation process and quality by design approach. *Pharmaceutics*, *12*(7), 598.
34. Alsulays, B. B., Anwer, M. K., Aldawsari, M. F., Aodah, A., Adam, E., Alshehri, S., & Abdel-Kader, M. S. (2019). Preparation and evaluation of a stable and sustained release of lansoprazole-loaded poly (d, l-lactide-co-glycolide) polymeric nanoparticles. *Journal of Polymer Engineering*, *39*(9), 822–829.
35. Aodah, A., Rawas-Qalaji, M., Bafail, R., & Rawas-Qalaji, M. (2019). Effect of fast-disintegrating tablets’ characteristics on the sublingual permeability of atropine sulfate for the potential treatment of organophosphates toxicity. *AAPS PharmSciTech*, *20*(6), 229.
36. Bafail, R., Rawas-Qalaji, M., Rawas-Qalaji, M., & Aodah, A. (2019). Effect of the filler grade on the characteristics and the sublingual permeability of atropine sulfate fast disintegrating sublingual tablets. *Drug Development and Industrial Pharmacy*, *45*(10), 1617–1623.
37. Aodah, A. (2017). *Formulation and Evaluation of Fast Disintegrating Sublingual Atropine Tablets for the Potential Treatment of Acute Organophosphates Toxicity* [Doctoral dissertation/Master's thesis, Nova Southeastern University].
38. Aodah, A., Bafail, R. S., & Rawas-Qalaji, M. (2017). Formulation and evaluation of fast-disintegrating sublingual tablets of atropine sulfate: the effect of tablet dimensions and drug load on tablet characteristics. *AAPS PharmSciTech*, *18*(5), 1624–1633.
39. Bafail, R., Alhussain, A., & Qalaji, M. (2016). Validation of a simple disintegration test for rapidly disintegrating tablets.
40. Bafail, R., Aodah, A., & Qalaji, M. (2016). Sublingual permeability of atropine sulfate using novel rapidly disintegrating tablets for the potential treatment of acute organophosphates.
41. Bafail, R., Aodah, A., & Qalaji, M. (2016). The effect of MCC grade on the physical properties of atropine sulfate rapidly disintegrating sublingual tablets.
42. Aodah, A., Bafail, R., & Rawas-Qalaji, M. (2015). Development and validation of a simple disintegration test for rapidly disintegrating tablets. *Orlando: American Association of Pharmaceutical Scientists Annual Meeting and Exposition*, R61.
43. AlHazme, R. H., Rana, A. M., & Aodah, A. (2014). Serious Arabic meaning, grammatical, and study design flaws in the study "Faxed Arabic Prescriptions: a medication error waiting to happen?". *International Journal of Medical Informatics*, *83*(8), 601–603.
44. Alaydi, L., Aodah, A., & Qalaji, M. R. (2014). Development and validation of HPLC method with PDA detector for simultaneous quantification of co-eluted compounds in pharmaceutical samples.
45. Aodah, A., Alaydi, L., & Qalaji, M. R. (2014). Validation of HPLC method and ultra violet detection for the quantification of atropine sulfate in aqueous samples.
46. Aodah, A., Mendez, B., Losada, A., & Qalaji, M. R. (2014). Fabrication and characterization of epinephrine nanocrystals using top-down technique.
47. Rawas-Qalaji, M., Kariman, A., Condon, M., Losada, A., Mandez, B., & Aodah, A. (2014). Formulation And Diffusion Of Epinephrine's Prodrug For Anaphylaxis Treatment.

Official government website of the Government of the Kingdom of Saudi Arabia

Links to official Saudi websites end with edu.sa

Government websites use the HTTPS protocol for encryption and security.

Dr.Alhussain Hamood Yahya Aodah

Education

Research Interests

Experience

Publications

Contact the university leaders

Administration of Public Relations and Media

Social

Official government website of the Government of the Kingdom of Saudi Arabia

Links to official Saudi websites end with edu.sa

Government websites use the HTTPS protocol for encryption and security.

Faculty Members

Dr.Alhussain Hamood Yahya Aodah

Education

Research Interests

Experience

Publications

Administration of Public Relations and Media